Clinical Trials Logo

Clinical Trial Summary

In this study, we aim to investigate the incidence of the adverse reactions, the effectiveness and the gene polymorphism associated with the plasma level of sulfamethoxazole-trimethoprim and their metabolites (including N4-acetyl-sulfamethoxazole, sulfamethoxazole hydroxylamine and sulfamethoxazole-nitroso). And we also aim to investigate the factors associated with the sulfamethoxazole-trimethoprim induced acute psychosis.


Clinical Trial Description

n/a


Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02045160
Study type Observational
Source National Taiwan University Hospital
Contact Jin-Han Yang, Bachelor
Phone 0975-103-277
Email r01451004@ntu.edu.tw
Status Recruiting
Phase N/A
Start date January 2014
Completion date December 2017

See also
  Status Clinical Trial Phase
Completed NCT04328688 - Clindamycin-trimethoprim/Sulfamethoxazole for PCP After Solid Organ Transplantation Population.
Active, not recruiting NCT05701631 - Radiomics Model for the Diagnosis of Pneumocystis Jirovecii Pneumonia in Non-HIV Patients